This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
New and existing investors put $77mm into Merrimack's Series G round
04 May 2011
Cancer company Merrimack Pharmaceuticals Inc. raised $77mm from 61 new and existing backers in its Series G round. Participants included Credit Suisse First Boston Next Fund, Crocker Ventures, funds associated with Fred Alger Management, funds managed by Noonday Asset Management, Jennison Associates, TPG-Axon Capital, and WT Investment Advisors Fund.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?